Skip to main content
. Author manuscript; available in PMC: 2024 Jul 19.
Published in final edited form as: Support Care Cancer. 2024 Apr 19;32(5):298. doi: 10.1007/s00520-024-08511-5

Table 1.

Participant characteristics overall and by age group.

Overall
(N=1,590)
YAs age 18–39
(n=81)
Age 40–49
(n=196)
Age 50–64
(n=627)
Age 65+
(n=686)
Age at diagnosis, M (SD) 61.50 (12.70) 34.12 (4.40) 45.12 (2.86) 57.37 (4.21) 73.19 (5.97)
Sex, n (%)
  Female 685 (43.1) 43 (53.1) 95 (48.5) 264 (42.1) 283 (41.3)
  Male 905 (56.9) 38 (46.9) 101 (51.5) 363 (57.9) 403 (58.7)
Race, n (%)
  White 1,434 (90.2) 75 (92.6) 172 (87.8) 545 (86.9) 642 (93.6)
  Black 95 (6.0) 2 (2.5) 12 (6.1) 52 (8.3) 29 (4.2)
  Other 54 (3.4) 4 (4.9) 11 (5.6) 27 (4.3) 12 (1.7)
  Missing 7 (0.4) 0 (0.0) 1 (0.5) 3 (0.5) 3 (0.4)
Ethnicity, n (%)
  Hispanic 63 (4.0) 5 (6.2) 13 (6.6) 29 (4.6) 16 (2.3)
  Non-Hispanic 1,521 (95.7) 76 (94.3) 183 (93.4) 594 (94.7) 668 (97.4)
  Missing 6 (0.4) 0 (0.0) 0 (0.0) 4 (0.6) 2 (0.3)
Smoking status, n (%)
  Never smoker 730 (45.9) 50 (61.7) 116 (59.2) 278 (44.3) 286 (41.7)
  Former smoker 584 (36.7) 20 (24.7) 46 (23.5) 215 (34.3) 303 (44.2)
  Current smoker 204 (12.8) 8 (9.9) 28 (14.3) 108 (17.2) 60 (8.7)
  Missing 72 (4.5) 3 (3.7) 6 (3.1) 26 (4.1) 37 (5.4)
BMI category, n (%)
  Underweight (<18.5) 34 (2.1) 4 (4.9) 5 (2.6) 7 (1.1) 18 (2.6)
  Healthy (18.5–24.9) 422 (26.5) 34 (42.0) 63 (32.1) 154 (24.6) 171 (24.9)
  Overweight (25.0–29.9) 600 (37.7) 26 (32.1) 64 (32.7) 251 (40.0) 259 (37.8)
  Obesity (≥30.0) 493 (31.0) 10 (12.3) 58 (29.6) 194 (30.9) 231 (33.7)
  Missing 41 (2.6) 7 (8.6) 6 (3.1) 21 (3.3) 7 (1.0)
Stage at diagnosis, n (%)
  0 64 (4.0) 2 (2.5) 3 (1.5) 21 (3.3) 36 (5.2)
  I 278 (17.5) 11 (13.6) 22 (11.2) 99 (15.8) 148 (21.6)
  II 387 (24.3) 16 (19.8) 37 (18.9) 140 (22.3) 192 (28.0)
  III 554 (34.8) 27 (33.3) 86 (43.9) 228 (36.4) 215 (31.3)
  IV 247 (15.5) 20 (24.7) 38 (19.4) 117 (18.7) 72 (10.5)
  Missing 60 (3.8) 5 (6.2) 10 (5.1) 22 (3.5) 23 (3.4)
Disease site, n (%)
  Colon 876 (55.1) 50 (61.7) 95 (48.5) 318 (50.7) 415 (60.5)
  Rectum 689 (43.3) 27 (33.3) 96 (49.0) 300 (47.8) 264 (38.5)
  Missing 25 (1.6) 4 (4.9) 5 (2.6) 9 (1.4) 7 (1.0)
Surgery, n (%)
  Yes 1,432 (90.1) 72 (88.9) 173 (88.3) 564 (90.0) 623 (90.8)
  No 100 (6.3) 4 (4.9) 17 (8.7) 40 (6.4) 39 (5.7)
  Missing 58 (3.6) 5 (6.2) 6 (3.1) 23 (3.7) 24 (3.5)
Neoadjuvant therapy, n (%)
  Yes 973 (61.2) 42 (51.9) 92 (46.9) 347 (55.3) 492 (71.7)
  No 548 (34.5) 32 (39.5) 97 (49.5) 254 (40.5) 165 (24.1)
  Missing 69 (4.3) 7 (8.6) 7 (3.6) 26 (4.1) 29 (4.2)
Adjuvant therapy, n (%)
  Yes 836 (52.6) 25 (30.9) 87 (44.4) 293 (46.7) 431 (62.8)
  No 613 (38.6) 46 (56.8) 96 (49.0) 268 (42.7) 203 (29.6)
  Missing 141 (8.9) 10 (12.3) 13 (6.6) 66 (10.5) 52 (7.6)

Note: BMI, body mass index calculated as kg/m2; YA, young adult. Percentages may not sum to 100 due to rounding